These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 17785808)
1. Blockade of hyaluronan inhibits IL-2-induced vascular leak syndrome and maintains effectiveness of IL-2 treatment for metastatic melanoma. Guan H; Nagarkatti PS; Nagarkatti M J Immunol; 2007 Sep; 179(6):3715-23. PubMed ID: 17785808 [TBL] [Abstract][Full Text] [Related]
2. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. Rafi-Janajreh AQ; Chen D; Schmits R; Mak TW; Grayson RL; Sponenberg DP; Nagarkatti M; Nagarkatti PS J Immunol; 1999 Aug; 163(3):1619-27. PubMed ID: 10415067 [TBL] [Abstract][Full Text] [Related]
3. Regulation of interleukin-2-induced vascular leak syndrome by targeting CD44 using hyaluronic acid and anti-CD44 antibodies. Mustafa A; McKallip RJ; Fisher M; Duncan R; Nagarkatti PS; Nagarkatti M J Immunother; 2002; 25(6):476-88. PubMed ID: 12439345 [TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. Rafi AQ; Zeytun A; Bradley MJ; Sponenberg DP; Grayson RL; Nagarkatti M; Nagarkatti PS J Immunol; 1998 Sep; 161(6):3077-86. PubMed ID: 9743374 [TBL] [Abstract][Full Text] [Related]
5. Functional roles of hyaluronan in B16-F10 melanoma growth and experimental metastasis in mice. Mummert ME; Mummert DI; Ellinger L; Takashima A Mol Cancer Ther; 2003 Mar; 2(3):295-300. PubMed ID: 12657724 [TBL] [Abstract][Full Text] [Related]
6. Role of CD44 in lymphokine-activated killer cell-mediated killing of melanoma. Sun J; Law GP; McKallip RJ Cancer Immunol Immunother; 2012 Mar; 61(3):323-34. PubMed ID: 21901391 [TBL] [Abstract][Full Text] [Related]
7. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491 [TBL] [Abstract][Full Text] [Related]
9. Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes. McKallip RJ; Fisher M; Do Y; Szakal AK; Gunthert U; Nagarkatti PS; Nagarkatti M J Biol Chem; 2003 Oct; 278(44):43818-30. PubMed ID: 12904302 [TBL] [Abstract][Full Text] [Related]
10. Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice. Ettinghausen SE; Puri RK; Rosenberg SA J Natl Cancer Inst; 1988 Apr; 80(3):177-88. PubMed ID: 3258039 [TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase (iNOS) is not required for IL-2-induced hypotension and vascular leak syndrome in mice. Kondapaneni M; McGregor JR; Salvemini D; Laubach VE; Samlowski WE J Immunother; 2008 May; 31(4):325-33. PubMed ID: 18391763 [TBL] [Abstract][Full Text] [Related]
12. Immunochemotherapy in B-16-melanoma-cell-transplanted mice with combinations of interleukin-2, cyclophosphamide, and PSK. Ueno Y; Kohgo Y; Sakamaki S; Itoh Y; Takahashi M; Hirayama Y; Niitsu Y Oncology; 1994; 51(3):296-302. PubMed ID: 8196915 [TBL] [Abstract][Full Text] [Related]
13. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma. Levesque MC; Haynes BF J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronan synthesis is required for IL-2-mediated T cell proliferation. Mahaffey CL; Mummert ME J Immunol; 2007 Dec; 179(12):8191-9. PubMed ID: 18056362 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. Mummert ME; Mummert D; Edelbaum D; Hui F; Matsue H; Takashima A J Immunol; 2002 Oct; 169(8):4322-31. PubMed ID: 12370364 [TBL] [Abstract][Full Text] [Related]
17. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases. Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534 [TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of IL-2Rbeta chain and its effects on IL-2-induced vascular leak syndrome. Assier E; Jullien V; Lefort J; Moreau JL; Vargaftig BB; Lapa e Silva JR; Thèze J Cytokine; 2005 Dec; 32(6):280-6. PubMed ID: 16378732 [TBL] [Abstract][Full Text] [Related]
19. A novel human IL-2 mutein with minimal systemic toxicity exerts greater antitumor efficacy than wild-type IL-2. Chen X; Ai X; Wu C; Wang H; Zeng G; Yang P; Liu G Cell Death Dis; 2018 Sep; 9(10):989. PubMed ID: 30250191 [TBL] [Abstract][Full Text] [Related]
20. Induction of vascular leak syndrome by tumor necrosis factor-alpha alone. Park KY; Kim SJ; Oh E; Heo TH Biomed Pharmacother; 2015 Mar; 70():213-6. PubMed ID: 25776503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]